Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

TPE24: Key Brands Showcased by Exhibiting Distributors

2Firsts Events by 2FIRSTS, edited by Sophia
Feb.01.2024
TPE24: Key Brands Showcased by Exhibiting Distributors
The TPE24 Tobacco Exhibition in Las Vegas opened on January 31, attracting major US distributors showcasing their brand products.

TPE24 tobacco exhibition is held in Las Vegas, Nevada, United States. At the event, 2FIRSTS observed several well-known American distributors showcasing their respective product brands and made a comprehensive inventory of them.

 

Unishow

 

Unishow brought VOZOL, RABBEATS, OFF STAMPSTAMP, LOST MARY, INSTA BAR, PRIV BAR, and more.

 

TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors

 

Vapor Beast

 

Vapor Beast presents a range of open-system products such as VOOPOO, VAPORESSO, SPREE BAR, SMOK, and more. They also offer a variety of e-liquid products including JUICE HEAD, COASTAL CLOUDS, MONSTEP VAPE LABS, CLOUD NURDZ, TWIST ELIQUIDS, POD JUICE, among others. They also carry nicotine pouch products like ZYN, FRE, ZIG-ZAG, COOKIES, GRAV, and more.

 

TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors
TPE24: Key Brands Showcased by Exhibiting Distributors

 

WW.VAPE

 

WW.VAPE brings Uwell, Unoverse, V-Play, and more to its customers.

 

TPE24: Key Brands Showcased by Exhibiting Distributors
盘点TPE24参展经销商的主推品牌
盘点TPE24参展经销商的主推品牌
盘点TPE24参展经销商的主推品牌

 

Empire Imports

 

Empire Imports brings popular brands such as Waka, Uwell, Geek Vape, Juul, Voopoo, Swft, Naked, Smok, Juice Head, and Twist.

 

盘点TPE24参展经销商的主推品牌
盘点TPE24参展经销商的主推品牌
盘点TPE24参展经销商的主推品牌
盘点TPE24参展经销商的主推品牌
盘点TPE24参展经销商的主推品牌

 

HAPPY DISTRO

 

HAPPY DISTRO offers brands like Chillax, iJoy, JUDO, LOST MARY, GEEK BAR, VOZOL, and more.

 

专访Happy Distro：分享GEEKBAR成功经验 认为产品设计极为重要

 

 

Also Read:
[1] Decrease in Attendance: TPE24 Opens with Fewer Visitors
[2] TPE24 Showcases Innovative Nicotine and Caffeine Products
[3] TPE24: SKE Introduces Innovative Tobacco Products
[4] FEELM's Latest Technological Solutions and Product Lineup Unveiled at TPE24
[5] TPE24: Full-Screen, Fast Charging, 20,000mAh Battery – Sneak Peek at Highlight Products
[6] FDA Participates in TPE24 to Promote Regulations and Policies
[7] TPE24: Exclusive Preview of the Exhibition Site | Live Photo Gallery
[8] Predicted Highlights for TPE24: Product, Brand, Marketing Trends
[9] TPE24: FDA will Participate and Set up Booth in Vape Area
[10] TPE 2024: List of More than 30 Vape Distributors from North America
[11] TPE 2024 Spotlight: Nearly 100 Global E-Cig Brands in Attendance
#North America#United States#Open system e-cigarettes#Brands#E-cigarette distributor#Major companies#TPE2024

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Regulation Shift：Policy Updates and Market Impact
China Tobacco Regulation Shift：Policy Updates and Market Impact
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
Related Topics
HEADLINE News Company
Related Read
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
2Firsts Perspectives
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2026 2FIRSTS. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland.
English
English
中文